Boardroom Alpha
Meeting calendar
LMB · Annual meeting · Tuesday, June 9, 2026

Limbach Holdings Inc

3 nominees · 4 ballot items.

Four proposals: (1) elect three Class A directors (Joshua S. Horowitz, Linda G. Alvarado, Terence P. Dugan) to three-year terms; (2) non-binding advisory vote to approve the compensation of the named executive officers (Say on Pay); (3) non-binding advisory vote on the frequency of future say-on-pay votes (every 1, 2, or 3 years); and (4) ratify the appointment of Crowe LLP as the company’s independent registered public accounting firm for fiscal year 2026.

Market cap
$867M
1Y TSR
-43.8%
Board grade
B-
Record date
Apr 17, 2026
Filing
DEF 14A
Meeting concluded · Jun 9, 2026

Follow how the vote landed and what changed on Limbach Holdings Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect Joshua S. Horowitz, Linda G. Alvarado and Terence P. Dugan as Class A members of the Board of Directors, each to serve a three-year term.

  2. 2

    Non-binding, advisory vote to approve the compensation of our named executive officers (Say on Pay

    ManagementBoard: FOR

    Advisory vote to approve the compensation paid to the company’s named executive officers as disclosed pursuant to Item 402 of Regulation S-K in this proxy statement.

    More detail

    This proposal asks stockholders to cast a non-binding advisory vote approving the compensation disclosed for the company’s named executive officers (the Say on Pay vote). Management is seeking this approval to obtain shareholder input and validate its compensation philosophy, which links pay to performance through a mix of base salary, short-term cash incentives tied to Adjusted EBITDA, and long-term equity awards that include service-based and market-based RSUs tied to relative TSR. The proposal is advisory and non-binding, but the Board and Compensation Committee state they will consider the outcome when making future compensation decisions; the company previously received strong stockholder support (approximately 97% in 2025) for its executive pay program. Key context includes the company’s shift to market-based RSUs tied to relative TSR beginning in 2025, the use of Adjusted EBITDA as a financial performance metric, and robust governance features such as an independent compensation committee and an independent compensation consultant. The board’s recommendation to vote FOR reflects its view that the program attracts and retains leadership, aligns executives with long-term stockholder value creation, and is justified by recent company performance and pay-for-performance outcomes. While the vote is non-binding, a large negative outcome could trigger review and potential changes to compensation practices; conversely, a strong affirmative vote reinforces current practices. Investors evaluating this proposal should weigh the alignment of pay metrics with strategic goals (ODR growth, margin expansion, disciplined M&A), the independence of oversight, and recent performance outcomes when forming a view.

  3. 3

    Non-binding, advisory vote on the frequency of future advisory votes on named executive officer compensation

    ManagementBoard: FOR

    Advisory vote to select how often (every 1 year, 2 years, or 3 years) the company should include a say-on-pay advisory vote in its proxy materials; the Board recommends every 1 year.

    More detail

    This proposal asks stockholders to choose the preferred frequency—every 1, 2, or 3 years—of the company’s non-binding advisory say-on-pay vote. Management (the Board and Compensation Committee) recommends an annual (every 1 year) advisory vote, arguing that it provides more frequent stockholder feedback on executive compensation and enables the Board to more regularly assess and incorporate investor perspectives. The vote is non-binding; however, the result serves as a signal to the Board and may influence the cadence of engagement and disclosures. Annual votes provide the clearest and most timely stockholder input, especially given iterative changes to compensation design (e.g., adoption of market-based RSUs tied to relative TSR in 2025) and the company’s recent strong performance metrics. A less frequent schedule (every two or three years) reduces administrative burden and short-termism but may limit investor ability to react to substantial compensation changes or outcomes. The company’s prior say-on-pay result (approximately 97% support in 2025) indicates strong shareholder alignment with current pay practices, which supports the Board’s recommendation for annual votes. Analysts evaluating governance trade-offs should consider the company’s track record of responsiveness, the non-binding nature of the vote, broker non-vote mechanics for discretionary brokerage accounts, and how vote frequency affects the signal value of future say-on-pay results.

  4. 4

    Ratification of appointment of independent registered public accounting firm (Crowe LLP

    ManagementBoard: FOR

    Ratify the Audit Committee’s appointment of Crowe LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Director elections

Nominees on the ballot3

Independent
Tenure on this board
6.3 yrs
Also a director at
Barnwell Industries Inc (BRN)Bk Technologies Corp (BKTI)Kingsway Corp (KWY)
Ownership

Top institutional holders10

Latest 13F quarter
1WASATCH ADVISORS LP8.1%969,639$76M
2Capital International Investors6.9%823,702$64M
3THRIVENT FINANCIAL FOR LUTHERANS5.9%704,489$55M
4VANGUARD CAPITAL MANAGEMENT LLC3.9%462,766$36M
5BlackRock, Inc.3.6%431,233$34M
6ROYCE ASSOCIATES LP3.2%380,764$30M
7FMR LLC2.8%332,283$26M
8NEUMEIER POMA INVESTMENT COUNSEL LLC2.6%313,938$25M
9CORSAIR CAPITAL MANAGEMENT, L.P.2.6%311,343$24M
10BlackRock, Inc.2.6%305,740$24M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Limbach Holdings Inc 2026 annual meeting?
Limbach Holdings Inc (LMB) holds its 2026 annual shareholder meeting on Tuesday, June 9, 2026.
What is the record date for the Limbach Holdings Inc 2026 meeting?
The record date for the Limbach Holdings Inc 2026 meeting is Friday, April 17, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Limbach Holdings Inc's 2026 meeting?
The board is presenting 3 director nominees at the Limbach Holdings Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Limbach Holdings Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Limbach Holdings Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer